<p>The aforementioned parameters are presented in Table 2 (Serum). Patients with primary sclerosing cholangitis (PSC) and cholangiocarcinoma (CC) were compared regarding demographics, laboratory and microRNA (miRNA) values. Data were expressed as number or median with interquartile range (IQR). ECC: extrahepatic cholangiocarcinoma; ICC: intrahepatic cholangiocarcinoma; ALT: alanine aminotransferase; AST: aspartate aminotransferase; AP: alkaline phosphatase; GGT: gamma-glutamyl transferase; CRP: C-reactive protein; WBC: white blood cells; CA 19–9: carbohydrate antigen 19–9.</p
Circulating levels of miR-122 (A), miR-192 (B), miR-29b (C) and miR-155 (D) are significantly elevat...
Abstract Background Primary sclerosing cholangitis (PSC) is a rare, chronic cholestatic liver diseas...
Early and differential diagnosis of intrahepatic cholangiocarcinoma (iCCA) and hepatocellular carcin...
<p>Sensitivity and specificity to distinguish between patients with primary sclerosing cholangitis (...
The diagnosis of primary sclerosing cholangitis (PSC) is difficult due to the lack of sensitive and ...
<p>Sensitivity and specificity to distinguish between patients with primary sclerosing cholangitis (...
<p>Serum validation analysis for patients with primary sclerosing cholangitis (PSC) (n = 40) and cho...
The diagnosis of primary sclerosing cholangitis (PSC) is difficult due to the lack of sensitive and ...
Patients with primary sclerosing cholangitis (PSC) are at high risk for the development of cholangio...
<p>Bile validation analysis for patients with primary sclerosing cholangitis (PSC) (n = 52), cholang...
The non-invasive differentiation of malignant and benign biliary disease is a clinical challenge. Ca...
Abstract. Cholangiocarcinoma (CCA) is a relatively rare type of primary liver cancer that originates...
<p>(A). Distribution of the serum OD value in cholangiocarcinoma (CC) patients, patients with benign...
UNLABELLED: Early detection of malignant biliary tract diseases, especially cholangiocarcinoma (CC) ...
Cholangiocarcinoma (CCA) includes a heterogeneous group of biliary cancers with poor prognosis. Seve...
Circulating levels of miR-122 (A), miR-192 (B), miR-29b (C) and miR-155 (D) are significantly elevat...
Abstract Background Primary sclerosing cholangitis (PSC) is a rare, chronic cholestatic liver diseas...
Early and differential diagnosis of intrahepatic cholangiocarcinoma (iCCA) and hepatocellular carcin...
<p>Sensitivity and specificity to distinguish between patients with primary sclerosing cholangitis (...
The diagnosis of primary sclerosing cholangitis (PSC) is difficult due to the lack of sensitive and ...
<p>Sensitivity and specificity to distinguish between patients with primary sclerosing cholangitis (...
<p>Serum validation analysis for patients with primary sclerosing cholangitis (PSC) (n = 40) and cho...
The diagnosis of primary sclerosing cholangitis (PSC) is difficult due to the lack of sensitive and ...
Patients with primary sclerosing cholangitis (PSC) are at high risk for the development of cholangio...
<p>Bile validation analysis for patients with primary sclerosing cholangitis (PSC) (n = 52), cholang...
The non-invasive differentiation of malignant and benign biliary disease is a clinical challenge. Ca...
Abstract. Cholangiocarcinoma (CCA) is a relatively rare type of primary liver cancer that originates...
<p>(A). Distribution of the serum OD value in cholangiocarcinoma (CC) patients, patients with benign...
UNLABELLED: Early detection of malignant biliary tract diseases, especially cholangiocarcinoma (CC) ...
Cholangiocarcinoma (CCA) includes a heterogeneous group of biliary cancers with poor prognosis. Seve...
Circulating levels of miR-122 (A), miR-192 (B), miR-29b (C) and miR-155 (D) are significantly elevat...
Abstract Background Primary sclerosing cholangitis (PSC) is a rare, chronic cholestatic liver diseas...
Early and differential diagnosis of intrahepatic cholangiocarcinoma (iCCA) and hepatocellular carcin...